SCHEMBL763435

SCHEMBL763435

CCCCNc1cc(OC)ccc1N

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 1/20 0.44
TLR8 Q9NR97 2/20 0.44
HDAC3 O15379 3/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC2 Q92769 2/20 0.43
HTR1A P08908 3/20 0.42
ADRA1D P25100 3/20 0.42
ADRA1A P35348 3/20 0.42
ADRA1B P35368 3/20 0.42
TDP1 Q9NUW8 1/20 0.42
APP P05067 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19312419 0.94 HTR1A (0.47) ALDH1A1CYP3A4HDAC3HDAC1HTR1A
SCHEMBL763898 0.85 PTGER4 (0.48) ALDH1A1CYP3A4HDAC3HDAC1HTR1A
SCHEMBL2019104 0.84 ALDH1A1 (0.48) ALDH1A1CYP3A4HDAC3HDAC1HDAC2
SCHEMBL29624960 0.84 ALDH1A1 (0.48) ALDH1A1CYP3A4HDAC3HDAC1HDAC2
SCHEMBL2219091 0.84 HDAC3 (0.46) ALDH1A1CYP3A4HDAC3HDAC1HTR1A
SCHEMBL16407615 0.83 PTGER4 (0.49) ALDH1A1CYP3A4HDAC3HDAC1HTR1A
SCHEMBL3897070 0.83 ALDH1A1 (0.47) ALDH1A1CYP3A4HDAC3HDAC1HTR1A
SCHEMBL16406450 0.83 HDAC3 (0.47) ALDH1A1CYP3A4HDAC3HDAC1HTR1A
SCHEMBL30712045 0.81 TDP1 (0.51) ALDH1A1CYP3A4HDAC3HDAC1HDAC2
SCHEMBL14141593 0.81 LMNA (0.55) ALDH1A1HDAC3HDAC1HDAC2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138168-B1 Renin inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-20 US disclosed